Search research articles
Contact Us
Filters
Showing results (21-30 of 34) with videos related to
Page
of 4
Sort By:
European Journal of Gastroenterology & Hepatology
|
January 26, 2012
Increased TLR2 expression on blood monocytes in irritable bowel syndrome patients
Lena Ohman, Ann-Charlotte Lindmark, Stefan Isaksson, et al.
Inflammatory Bowel Diseases
|
June 16, 2006
Functional CD4+CD25high regulatory T cells are enriched in the colonic mucosa of patients with active ulcerative colitis and increase with disease activity
Nathalie Holmén, Anna Lundgren, Samuel Lundin, et al.
Gastroenterology
|
July 17, 2018
Rome Foundation Working Team Report on Post-Infection Irritable Bowel Syndrome
Giovanni Barbara, Madhusudan Grover, Premysl Bercik, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
October 24, 2015
Lactulose Challenge Determines Visceral Sensitivity and Severity of Symptoms in Patients With Irritable Bowel Syndrome
Boris Le Nevé, Rémi Brazeilles, Muriel Derrien, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
April 5, 2016
Reply
Boris Le Nevé, Rémi Brazeilles, Muriel Derrien, et al.
The American Journal of Gastroenterology
|
April 16, 2009
T-cell activation in patients with irritable bowel syndrome
Lena Ohman, Stefan Isaksson, Ann-Charlotte Lindmark, et al.
Journal of Crohn'S & Colitis
|
January 15, 2014
Fecal calprotectin one year after ileocaecal resection for Crohn's disease--a comparison with findings at ileocolonoscopy
Anders Lasson, Hans Strid, Lena Ohman, et al.
Journal of Innate Immunity
|
April 9, 2010
CD8- natural killer cells are greatly enriched in the human gastrointestinal tract and have the capacity to respond to bacteria
Asa Lindgren, Cheol H Yun, Anna Lundgren, et al.
United European Gastroenterology Journal
|
June 12, 2014
CD25 and TNF receptor II reflect early primary response to infliximab therapy in patients with ulcerative colitis
Maria K Magnusson, Rahil Dahlén, Hans Strid, et al.
Inflammatory Bowel Diseases
|
August 23, 2013
Serum IL-17A in newly diagnosed treatment-naive patients with ulcerative colitis reflects clinical disease severity and predicts the course of disease
Lena Ohman, Rahil Dahlén, Stefan Isaksson, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 34) with videos related to
Sort By:
Page
of 4
European Journal of Gastroenterology & Hepatology
|
January 26, 2012
Increased TLR2 expression on blood monocytes in irritable bowel syndrome patients
Lena Ohman, Ann-Charlotte Lindmark, Stefan Isaksson, et al.
Inflammatory Bowel Diseases
|
June 16, 2006
Functional CD4+CD25high regulatory T cells are enriched in the colonic mucosa of patients with active ulcerative colitis and increase with disease activity
Nathalie Holmén, Anna Lundgren, Samuel Lundin, et al.
Gastroenterology
|
July 17, 2018
Rome Foundation Working Team Report on Post-Infection Irritable Bowel Syndrome
Giovanni Barbara, Madhusudan Grover, Premysl Bercik, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
October 24, 2015
Lactulose Challenge Determines Visceral Sensitivity and Severity of Symptoms in Patients With Irritable Bowel Syndrome
Boris Le Nevé, Rémi Brazeilles, Muriel Derrien, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
April 5, 2016
Reply
Boris Le Nevé, Rémi Brazeilles, Muriel Derrien, et al.
The American Journal of Gastroenterology
|
April 16, 2009
T-cell activation in patients with irritable bowel syndrome
Lena Ohman, Stefan Isaksson, Ann-Charlotte Lindmark, et al.
Journal of Crohn'S & Colitis
|
January 15, 2014
Fecal calprotectin one year after ileocaecal resection for Crohn's disease--a comparison with findings at ileocolonoscopy
Anders Lasson, Hans Strid, Lena Ohman, et al.
Journal of Innate Immunity
|
April 9, 2010
CD8- natural killer cells are greatly enriched in the human gastrointestinal tract and have the capacity to respond to bacteria
Asa Lindgren, Cheol H Yun, Anna Lundgren, et al.
United European Gastroenterology Journal
|
June 12, 2014
CD25 and TNF receptor II reflect early primary response to infliximab therapy in patients with ulcerative colitis
Maria K Magnusson, Rahil Dahlén, Hans Strid, et al.
Inflammatory Bowel Diseases
|
August 23, 2013
Serum IL-17A in newly diagnosed treatment-naive patients with ulcerative colitis reflects clinical disease severity and predicts the course of disease
Lena Ohman, Rahil Dahlén, Stefan Isaksson, et al.
Page
of 4